On November 18-21, in Germany, Dusseldorf will host one of the most ambitious world events in the field of healthcare - the international exhibition "MEDICA 2019". Alkor Bio Group of Companies, the largest manufacturer of test systems for laboratory diagnostics in Northwest Russia, will take part in this event at the stand of the Government of St. Petersburg at the invitation of the Committee for Industrial Policy and Innovation of St. Petersburg (stand No. 10, hall 15).

In October Alkor Bio Group of Companies – Russian designer and manufacturer of ELISA and PCR diagnostic kits - has been assessed for compliance with the International standard ISO 13485:2016. 

In late August, Alkor Bio Group of Companies - the developer and manufacturer of test systems for laboratory diagnostics by ELISA and PCR methods - received a registration certificate from the Russian Healthcare Agency for its new kit of “Intifica Ureaplasma species” for detecting DNA of microorganisms of the genus Ureaplasma (U. parvum, U. urealyticum) by PCR with hybridization-fluorescence detection in real time.

In mid-August, the opening of a new modern vivarium took place in the Alkor Bio Group of Companies. Vivarium is located in a separate two-story building with a total area of ​​1018 square meters next to the main building of Alkor Bio Group of Companies. Alkor Bio Group of Companies, a developer and manufacturer of test systems for laboratory diagnostics, invested more than 67.5 million rubles in the reconstruction and equipping of the vivarium. 

In mid-May, Alkor Bio Group of Companies, a developer and manufacturer of laboratory diagnostic reagent kits, announced a significant expansion of the range of oligonucleotides that it is ready to synthesize for third-party organizations. We are talking about the synthesis of simple and modified oligonucleotides, including probes for real-time PCR.

In April 2019, Microbiology laboratory of Alkor bio Group has launched a new product: cytomegalovirus (CMV) antigen (strain AD-169). This antigen can be used as a specific component in the various test systems, intended for the diagnosis CMV infection in the research laboratories and production. CMV antigen is an inactivated component. Today, the laboratory is working on other viral antigens.